×
Covalon Technologies Total Assets 2013-2024 | CVALF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Covalon Technologies total assets from 2013 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
View More
Covalon Technologies Total Assets 2013-2024 | CVALF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Covalon Technologies total assets from 2013 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$234.6B
Intuitive Surgical (ISRG)
$174.6B
Alcon (ALC)
$48.6B
IQVIA Holdings (IQV)
$43.6B
IDEXX Laboratories (IDXX)
$42.1B
Edwards Lifesciences (EW)
$41.8B
DexCom (DXCM)
$28.1B
STERIS (STE)
$24B
SONOVA HOLDING (SONVY)
$21.5B
Waters (WAT)
$19.5B
Hologic (HOLX)
$19.2B
Sysmex ADR (SSMXY)
$12.3B
Fresenius Medical Care AG KGaA (FMS)
$12.3B
Teleflex (TFX)
$11.6B
Globus Medical (GMED)
$9.5B
Penumbra (PEN)
$7.3B
Glaukos (GKOS)
$6.8B
Masimo (MASI)
$6.1B
TransMedics (TMDX)
$5B
Integer Holdings (ITGR)
$4.3B
PROCEPT BioRobotics (PRCT)
$4.3B
Tandem Diabetes Care (TNDM)
$2.8B
Inari Medical (NARI)
$2.7B
LivaNova (LIVN)
$2.6B
Nihon Kohden (NHNKY)
$2.6B
Veracyte (VCYT)
$2.6B
Elekta AB (EKTAY)
$2.4B
RxSight (RXST)
$2.1B
Integra LifeSciences Holdings (IART)
$1.3B
Pulse Biosciences (PLSE)
$1.2B